Current Firm
OrbiMed Advisors
Investments
1+ companies
Focus
Biotech, Digital Health
Geoffrey C. Hsu is a General Partner at OrbiMed Advisors, a leading investment firm focused on the healthcare and life sciences sectors. With expertise spanning biotech, digital health, and artificial intelligence, Hsu identifies and evaluates innovative companies positioned to transform healthcare delivery and outcomes. At OrbiMed Advisors, he leverages deep industry knowledge to support portfolio companies through capital deployment, strategic guidance, and operational expertise. His investment approach focuses on identifying promising founders and technologies at the intersection of biology and technology. Hsu's career reflects a commitment to advancing healthcare innovation through venture capital, with a track record of supporting transformative companies in highly competitive and rapidly evolving markets.
Geoffrey C. Hsu is a General Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY.
Geoffrey's investment focus spans Biotech, Digital Health, AI, primarily investing at the Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Carl L. Gordon. These investments span Biotech and Digital Health.
Geoffrey C. Hsu is a General Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY. Their investment focus includes Biotech, Digital Health, AI.
Geoffrey C. Hsu focuses on investments in Biotech, Digital Health, AI through OrbiMed Advisors. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Geoffrey C. Hsu's notable portfolio investments include Carl L. Gordon. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Geoffrey C. Hsu is currently at OrbiMed Advisors, headquartered in New York, NY, serving as General Partner, OrbiMed Advisors.